Most cited papers from Hôpital Européen
What are the most cited papers from Hôpital Européen?
The most cited paper from Hôpital Européen is "The Hallmarks of Aging" (Carlos López-Otı́n, Marı́a A. Blasco, Linda Partridge et al., 2013), with 15,388 citations. Next come "Hepatocellular carcinoma" (6,733) and "Hallmarks of aging: An expanding universe" (6,477).
Showing 50 of 60 papers. Every paper with more than 1,142 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | The Hallmarks of Aging Carlos López-Otı́n, Marı́a A. Blasco, Linda Partridge et al. · Cell | Jun 2013 | 15,388 |
| 2 | Hepatocellular carcinoma Josep Maria Llovet, Robin Kate Kelley, Augusto García Villanueva et al. · Nature Reviews Disease Primers | 21 Jan 2021 | 6,733 |
| 3 | Hallmarks of aging: An expanding universe Carlos López-Otı́n, Marı́a A. Blasco, Linda Partridge et al. · Cell | 2023 | 6,477 |
| 4 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Daniel J. Klionsky et al. · Autophagy | 2 Jan 2016 | 6,023 |
| 5 | Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma Robert John Motzer, Thomas E. Hutson, Piotr Tomczak et al. · New England Journal of Medicine | 10 Jan 2007 | 5,801 |
| 6 | Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer Ian F. Tannock, Ronald de Wit, William R. Berry et al. · New England Journal of Medicine | 6 Oct 2004 | 5,779 |
| 7 | The consensus molecular subtypes of colorectal cancer Justin Guinney et al. · Nature Medicine | 12 Oct 2015 | 5,415 |
| 8 | Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma Bernard J. Escudier, Tim G Eisen, Walter Michael Stadler et al. · New England Journal of Medicine | 10 Jan 2007 | 4,813 |
| 9 | Ferroptosis: molecular mechanisms and health implications Daolin Tang, Xin Chen, Rui Kang et al. · Cell Research | 2 Dec 2020 | 4,365 |
| 10 | Autophagy and the Integrated Stress Response Guido Kroemer, Guillermo Mariño, Beth Levine · Molecular Cell | Oct 2010 | 3,556 |
| 11 | Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota Marie Vétizou et al. · Science | 5 Nov 2015 | 3,498 |
| 12 | Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial Johann Sebastian De Bono, Stéphane Marie. Oudard, Mustafa Özgüroğlu et al. · The Lancet | Oct 2010 | 3,328 |
| 13 | Immunogenic Cell Death in Cancer Therapy Guido Kroemer, Lorenzo Galluzzi, Oliver Kepp et al. · Annual Review of Immunology | 16 Nov 2012 | 3,313 |
| 14 | Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients Jérôme Hadjadj et al. · Science | 13 Jul 2020 | 3,200 |
| 15 | Immunogenic cell death in cancer and infectious disease Lorenzo Galluzzi, Aitziber Buqué, Oliver Kepp et al. · Nature reviews. Immunology | 17 Oct 2016 | 3,145 |
| 16 | Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial Robert John Motzer, Bernard J. Escudier, Stéphane Marie. Oudard et al. · The Lancet | 23 Jul 2008 | 3,036 |
| 17 | Broadening horizons: the role of ferroptosis in cancer Xin Chen, Rui Kang, Guido Kroemer et al. · Nature Reviews Clinical Oncology | 29 Jan 2021 | 3,006 |
| 18 | Biological Functions of Autophagy Genes: A Disease Perspective Beth Levine, Guido Kroemer · Cell | 2019 | 2,917 |
| 19 | Ventilator-associated Pneumonia Jean E. Chastre, Jean-Yves Fagon · American Journal of Respiratory and Critical Care Medicine | Apr 2002 | 2,838 |
| 20 | 2018 ESC/ESH Guidelines for the management of arterial hypertension Bryan Williams et al. · Journal of Hypertension | Oct 2018 | 2,833 |
| 21 | Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline Jacques W.M. Lenders, Quan‐Yang Duh, Graeme Eisenhofer et al. · The Journal of Clinical Endocrinology & Metabolism | Jun 2014 | 2,828 |
| 22 | Molecular mechanisms of cisplatin resistance Lorenzo Galluzzi, Laura Senovilla, Ilio Vitale et al. · Oncogene | 5 Sep 2011 | 2,825 |
| 23 | The molecular machinery of regulated cell death Daolin Tang, Rui Kang, Tom Vanden Berghe et al. · Cell Research | 4 Apr 2019 | 2,601 |
| 24 | Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012 Lorenzo Galluzzi et al. · Cell Death and Differentiation | 15 Jul 2011 | 2,444 |
| 25 | Molecular mechanisms of necroptosis: an ordered cellular explosion Peter Vandenabeele, Lorenzo Galluzzi, Tom Vanden Berghe et al. · Nature Reviews Molecular Cell Biology | 8 Sep 2010 | 2,402 |
| 26 | The immune contexture in cancer prognosis and treatment Wolf H. Fridman, Laurence Zitvogel, Catherine Sautès‐Fridman et al. · Nature Reviews Clinical Oncology | 25 Jul 2017 | 2,367 |
| 27 | KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer Astrid Lièvre, Jean‐Baptiste Bachet, Delphine Le Corre et al. · Cancer Research | 15 Apr 2006 | 2,241 |
| 28 | Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization Delphine Planas et al. · Nature | 8 Jul 2021 | 2,187 |
| 29 | Autophagy and Aging David Chaim Rubinsztein, Guillermo Mariño, Guido Kroemer · Cell | Sep 2011 | 2,112 |
| 30 | The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide Sophie Viaud et al. · Science | 21 Nov 2013 | 2,053 |
| 31 | The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited Jan J. Weening et al. · Journal of the American Society of Nephrology | Feb 2004 | 2,021 |
| 32 | Macrophages and Metabolism in the Tumor Microenvironment Ilio Vitale, Gwenola Manic, Lisa M. Coussens et al. · Cell Metabolism | Jul 2019 | 1,928 |
| 33 | Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets Kornelius Schulze et al. · Nature Genetics | 30 Mar 2015 | 1,896 |
| 34 | 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension Giuseppe Mancia, Guy De Backer, Anna F. Dominiczak et al. · Journal of Hypertension | 6 Aug 2007 | 1,846 |
| 35 | Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation Jean‐François Obadia et al. · New England Journal of Medicine | 27 Aug 2018 | 1,797 |
| 36 | Molecular definitions of autophagy and related processes Lorenzo Galluzzi et al. · The EMBO Journal | 8 Jun 2017 | 1,670 |
| 37 | Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document Giuseppe Mancia et al. · Journal of Hypertension | 21 Oct 2009 | 1,659 |
| 38 | 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) Stavros Konstantinides et al. · European Respiratory Journal | 31 Aug 2019 | 1,646 |
| 39 | Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism Gary E. Raskob, Nick van Es, Peter B. Verhamme et al. · New England Journal of Medicine | 12 Dec 2017 | 1,633 |
| 40 | Considerable escape of SARS-CoV-2 Omicron to antibody neutralization Delphine Planas et al. · Nature | 23 Dec 2021 | 1,625 |
| 41 | Complement System Part I – Molecular Mechanisms of Activation and Regulation Nicolas S. Merle, S. Church, Véronique Frémeaux‐Bacchi et al. · Frontiers in Immunology | 2 Jun 2015 | 1,618 |
| 42 | Autophagy in major human diseases Daniel J. Klionsky et al. · The EMBO Journal | 30 Aug 2021 | 1,608 |
| 43 | Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value Laëtitia Marisa et al. · PLoS Medicine | 21 May 2013 | 1,590 |
| 44 | Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Disease Christine M. Eng, Nathalie Guffon, William Ross Wilcox et al. · New England Journal of Medicine | 5 Jul 2001 | 1,559 |
| 45 | Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents Lorenzo Galluzzi, Aitziber Buqué, Oliver Kepp et al. · Cancer Cell | Dec 2015 | 1,549 |
| 46 | Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma Cécile Guichard, Giuliana Amaddeo, Sandrine Imbeaud et al. · Nature Genetics | 6 May 2012 | 1,489 |
| 47 | Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy Jonathan M. Pitt, Aurélien Marabelle, Alexander M.M. Eggermont et al. · Annals of Oncology | 11 Apr 2016 | 1,406 |
| 48 | Acetyl Coenzyme A: A Central Metabolite and Second Messenger Federico Pietrocola, Lorenzo Galluzzi, José Manuel Bravo‐San Pedro et al. · Cell Metabolism | Jun 2015 | 1,399 |
| 49 | Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors Lorenzo Galluzzi, Juliette F Humeau, Aitziber Buqué et al. · Nature Reviews Clinical Oncology | 5 Aug 2020 | 1,375 |
| 50 | Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice Mickaël Michaud, Isabelle Martins, Abdul Qader Sukkurwala et al. · Science | 15 Dec 2011 | 1,361 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.